Get the Stockscreener App
200.89
0.23%
0.46
After Hours:
200.95
0.06
+0.03%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $200.89, with a volume of 2.47M.
It is up +0.23% in the last 24 hours and up +4.56% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$200.43
Open:
$200.47
24h Volume:
2.47M
Relative Volume:
1.25
Market Cap:
$57.34B
Revenue:
$21.84B
Net Income/Loss:
$1.68B
P/E Ratio:
34.46
EPS:
5.8293
Net Cash Flow:
$2.67B
1W Performance:
+3.57%
1M Performance:
+4.56%
6M Performance:
+15.15%
1Y Performance:
-11.57%
1-Day Range:
$198.40
$202.75
1-Week Range:
$188.52
$202.75
52-Week Range:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Benjamin Edwards Inc. Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Banque Transatlantique SA Has $2.83 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety - GlobeNewswire
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity - Yahoo Finance
Waters-Becton, Dickinson deal deadline expires in the US - MLex
Waters-Becton-Dickinson deal receives antitrust clearance in the US - MLex
Becton, Dickinson Reaches Analyst Target Price - Nasdaq
Becton Dickinson Shares Gain on Strategic Optimism and Product Launches - Ad-hoc-news.de
Morgan Stanley Highlights Positive Outlook for Becton, Dickinson (BDX) and the MedTech Sector - Finviz
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.60 Million Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Cary Street Partners Financial LLC - MarketBeat
Jefferies Adjusts PT on Becton, Dickinson and Co. to $220 From $215, Maintains Buy Rating - marketscreener.com
Jefferies raises Becton Dickinson stock price target to $220 on deal implications By Investing.com - Investing.com South Africa
Jefferies raises Becton Dickinson stock price target to $220 on deal implications - Investing.com Nigeria
Natixis Has $10.33 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
First Trust Advisors LP Has $47.38 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Cell Analyzers | Becton Dickinson & Co. | Products - Photonics Spectra
California Public Employees Retirement System Has $183.46 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company: - marketscreener.com
Amundi Increases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX): Revisiting Valuation After a Recent Share Price Rebound - simplywall.st
Becton Dickinson: Pharmaceutical Systems & Core Medical Consumables as Durable Growth Anchors! - Smartkarma
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing - Yahoo Finance
Investors Buy Large Volume of Becton, Dickinson and Company Call Options (NYSE:BDX) - MarketBeat
Vascular Access Devices Market Set for Dynamic Growth with Key Players Becton, Dickinson and Company, Cook - EIN News
Philadelphia Trust Co. Acquires 27,495 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Is Becton Dickinson and Company (BOX) stock a buy for dividend portfoliosWeekly Profit Report & Verified Technical Trade Signals - Newser
Becton Dickinson & Co To Go Ex-Dividend On December 8th, 2025 With 1.05 USD Dividend Per Share - 富途牛牛
Ex-Dividend Reminder: Becton, Dickinson, Nicolet Bankshares and UnitedHealth Group - Nasdaq
BD and ChemoGLO collaborate to expand hazardous drug contamination testing for healthcare facilities and laboratories - marketscreener.com
BD and ChemoGLO Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories - Finviz
Becton, Dickinson & Co. Working With ChemoGLO Partner to Broaden Hazardous Drug Contamination Testing - marketscreener.com
BD and ChemoGLO partner to enhance hazardous drug testing in healthcare By Investing.com - Investing.com South Africa
BD and ChemoGLO partner to enhance hazardous drug testing in healthcare - Investing.com
BD (NYSE: BDX), ChemoGLO partner to speed hazardous drug surface testing to 10 minutes - Stock Titan
Becton, Dickinson and Company (BDX) Stock Forecasts - Yahoo! Finance Canada
1832 Asset Management L.P. Boosts Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
There May Be Reason For Hope In Becton Dickinson's (NYSE:BDX) Disappointing Earnings - Yahoo Finance
Feld Michael, EVP at Becton Dickinson, sells $14502 in stock By Investing.com - Investing.com South Africa
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $210 - 富途牛牛
Hundreds of jobs saved at Swindon factory after buyout of US firm - This is Wiltshire
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes - Finviz
Becton, Dickinson Launches New Cell Analyzer Configurations - marketscreener.com
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld Michael, EVP at Becton Dickinson, sells $14502 in stock - Investing.com
BECTON DICKINSON EVP Michael Feld Sells 75 Shares - TradingView
VP Feld Sells 75 ($14.5K) Of Becton Dickinson & Co [BDX] - TradingView
BDX: Morgan Stanley Raises Price Target on Becton Dickinson | BD - GuruFocus
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $210 - 富途牛牛
Becton, Dickinson and Company: Target Price Consensus and Analysts Recommendations | BDX | US0758871091 - marketscreener.com
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):